Clinical Trial Update: Reversal of Botulinum Neurotoxin Injection Related Dysphonia With Pyridostigmine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating reversal of botulinum toxin–related dysphonia using pyridostigmine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysphonia
• Dysphonia Spastic
• Laryngeal Dystonia

Drugs mentioned

• Pyridostigmine (pyridostigmine)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Dysphonia, Spastic, Dysphonia | Phase 4 | Status: UNKNOWN